Axon Enterprise, Inc $AXON Shares Purchased by Sowell Financial Services LLC

Key Points

• Sowell Financial Services increased its Axon Enterprise stake by 1,652% in the third quarter, purchasing 134,359 additional shares to hold 142,492 shares valued at approximately $60.2 million.
• Axon shares opened at $392.64, well below the 12-month high of $764.02, while analysts maintained a generally positive outlook with a “Moderate Buy” consensus and an average price target of $707.07.
• Insiders sold 47,397 shares worth approximately $26.7 million over the past three months under pre-arranged trading plans, including sales by CEO Patrick Smith and insider Isaiah Fields.

Sowell Financial Services LLC lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,652.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 142,492 shares of the biotechnology company's stock after purchasing an additional 134,359 shares during the period. Axon Enterprise makes up 1.6% of Sowell Financial Services LLC's holdings, making the stock its 9th biggest holding. Sowell Financial Services LLC owned approximately 0.18% of Axon Enterprise worth $60,206,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the business. Pure Financial Advisors LLC boosted its holdings in Axon Enterprise by 6.7% in the fourth quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company's stock valued at $207,000 after purchasing an additional 23 shares during the period. Keel Point LLC raised its position in Axon Enterprise by 4.4% in the 1st quarter. Keel Point LLC now owns 599 shares of the biotechnology company's stock valued at $254,000 after purchasing an additional 25 shares in the last quarter. Bridgewater Advisors Inc. raised its position in Axon Enterprise by 4.4% in the 2nd quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company's stock valued at $352,000 after purchasing an additional 26 shares in the last quarter. Roman Butler Fullerton & Co. raised its position in Axon Enterprise by 2.4% in the 1st quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company's stock valued at $500,000 after purchasing an additional 30 shares in the last quarter. Finally, 44 Wealth Management LLC boosted its stake in shares of Axon Enterprise by 6.0% in the 1st quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company's stock valued at $225,000 after buying an additional 30 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is expected to report third-quarter results soon, with analysts anticipating a substantial year-over-year increase in earnings per share. The earnings preview may be supporting optimism about continued revenue and profit growth. Earnings Preview: What to Expect From Axon Enterprise’s Report
• Positive Sentiment: Bloomington approved an expanded agreement with Axon for policing technology, while the Reno City Council is set to vote on a proposed $22 million deal. Additional municipal contracts could reinforce Axon’s recurring-revenue model and strengthen demand for its connected hardware and cloud software. Bloomington council OKs expanded agreement with Axon for policing technology City of Reno council to vote on $22M Axon tech deal
• Positive Sentiment: Commentary from The Motley Fool describes Axon as a potential buy after a roughly 54% decline, arguing that recent pressure appears largely short-term and that the company retains a dominant position in public safety. Down 54%, This Tech Stock Looks Like a Buy With or Without AI
• Neutral Sentiment: Piper Sandler maintained an “overweight” rating but reduced its AXON price target from $732 to $561. The target cut signals more cautious near-term expectations, although it still implies significant potential upside based on the cited trading level.
• Neutral Sentiment: A comparison with Arista Networks emphasizes Axon’s integrated hardware-and-cloud platform and strong public-safety market position, but it is an opinion piece rather than a new company-specific catalyst. Arista Networks vs. Axon Enterprise
• Neutral Sentiment: Reports concerning an “Axon Graphite” spin-out by Lithium Energy and a reverse stock split by Axonex AI Group are unrelated to Axon Enterprise, Inc. (AXON) and should not affect its shares.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick Smith sold 10,000 shares of the firm's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares of the company's stock, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares of the company's stock, valued at $27,032,038.80. The trade was a 1.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 47,397 shares of company stock valued at $26,722,984 over the last three months. Insiders own 4.20% of the company's stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $392.64 on Wednesday. The company has a market cap of $31.90 billion, a price-to-earnings ratio of 162.92, a price-to-earnings-growth ratio of 7.21 and a beta of 1.44. The stock has a 50 day simple moving average of $492.46 and a 200-day simple moving average of $474.34. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $764.02. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the previous year, the firm earned $2.12 earnings per share. The firm's revenue was up 35.3% on a year-over-year basis. On average, equities analysts forecast that Axon Enterprise, Inc will post 2.12 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. TD Cowen restated a "buy" rating on shares of Axon Enterprise in a report on Tuesday, October 13th. Raymond James Financial set a $675.00 price objective on shares of Axon Enterprise in a research report on Thursday, October 15th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Morgan Stanley boosted their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an "overweight" rating in a research note on Thursday, August 6th. Finally, Argus increased their target price on Axon Enterprise from $460.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $707.07.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.